跳至主要内容
临床试验/ISRCTN79006041
ISRCTN79006041进行中(未招募)未知

Can a remotely monitored, home-based exercise intervention for individuals with type 1 diabetes reduce immune-driven disease activity?

niversity of Birmingham0 个研究点目标入组 20 人开始时间: 2022年1月20日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
入组人数
20

研究概览

简要总结

2024 Protocol article in https://pubmed.ncbi.nlm.nih.gov/39224197/ (added 03/09/2024)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Current inclusion criteria as of 14/11/2023:
  • 1. Aged over 18 years
  • 2. Clinical diagnosis of T1D made within the last 3 years
  • 3. Confirmed clinical diagnosis of T1D
  • 4. Confirmed HLA-A2*0201+ genotype
  • 5. Self administering their insulin as part of a multiple dose injection regime or insulin pump therapy.
  • 6. Both participant and physician feel that they are able to exercise safely.
  • 7. Patient is able to estimate carbohydrate content of meals
  • 8. Patient is willing to test glucose and adjust insulin and carbohydrate doses accordingly
  • 9. Patients will be able to recognise hypoglycaemic symptoms before capillary blood glucose falls to 3.5mmol/L
  • 10. Compliance: understands and is willing, able and likely to comply with all study procedures and restrictions.
  • 11. Consent: demonstrates an understanding of the study and willingness to participate, as evidenced by voluntary written informed consent.
  • Previous inclusion criteria:
  • 1. Aged over 18 years
  • 2. Clinical diagnosis of T1D made within the last 1 year
  • 3. Confirmed diagnosis of T1D via T1D-GRS2
  • 4. Confirmed HLA-A2*0201+ genotype
  • 5. Self administering their insulin as part of a multiple dose injection regime or insulin pump therapy.
  • 6. Both participant and physician feel that they are able to exercise safely.
  • 7. Patient is able to estimate carbohydrate content of meals
  • 8. Patient is willing to test glucose and adjust insulin and carbohydrate doses accordingly
  • 9. Patients will be able to recognise hypoglycaemic symptoms before capillary blood glucose falls to 3.5mmol/L
  • 10. Compliance: understands and is willing, able and likely to comply with all study procedures and restrictions.
  • 11. Consent: demonstrates an understanding of the study and willingness to participate, as evidenced by voluntary written informed consent.

排除标准

  • Current exclusion criteria as of 14/11/2023:
  • 1. Uncontrolled blood pressure
  • 2. Pregnancy or planning pregnancy
  • 3. Currently engaging in more than 150 minutes of exercise per week
  • 4. Additional health conditions that might put the participant at risk for this study e.g. cardiac disease, active proliferative diabetic retinopathy, autonomic neuropathy and/or a history of severe hypoglycaemia requiring third party assistance within the last 3 months. Any other condition (medical or psychological) that is deemed inappropriate will be at the PI’s discretion.
  • 5. Unable to provide full informed consent.
  • Previous exclusion criteria:
  • 1. Uncontrolled blood pressure
  • 2. Pregnancy or planning pregnancy
  • 3. Adhering to the current recommended physical activity guidelines (> 150 minutes)
  • 4. Additional health conditions that might put the participant at risk for this study e.g. cardiac disease, active proliferative diabetic retinopathy, autonomic neuropathy and/or a history of severe hypoglycaemia requiring third party assistance within the last 3 months. Any other condition (medical or psychological) that is deemed inappropriate will be at the PI’s discretion.
  • 5. Unable to provide full informed consent.

研究者

相似试验